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Backgroud: Cardiac surgery with cardiopulmonary bypass (CPB) may cause inflammatory responses, which can
deteriorate the outcomes. Inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-6,–8 and -10,
can act as both the effector and the predictor for post-operative inflammatory responses. Plasma mitochondrial DNA
(mtDNA) was found as a pro-inflammatory agent recently, which was released when cells were insulted.
Methods: In the present study, we included 38 patients undergoing coronary artery bypass graft (CABG) to analyze
their perioperative plasma mtDNA and levels of inflammatory cytokines. Blood samples were collected before aortic
cross-clamping (T1), at the end of CPB (T2), 6 h post-CPB (T3), 12 h post-CPB (T4), and 24 h post-CPB (T5). Rt-PCR
and specific ELISA kits were used to quantify the plasma mtDNA and inflammatory cytokines, respectively.
Bivariate correlations analysis was used to check the correlations between plasma mtDNA and inflammatory
cytokines respectively.
Results: Results shown that plasma mtDNA elevated significantly at T2 and peaked at T4. Furthermore, plasma
TNF-α, IL-6 and IL-8 levels significantly increased at T2 and peaked at T3 while IL-10 elevated and peaked at T2.
Bivariate correlations analysis showed that the peak plasma mtDNA were positively correlated with the peak
TNF-α (r = 0.677, P < 0.001), the peak IL-6 (r = 0.706, P < 0.001), the peak IL-8 (r = 0.584, P < 0.001) and the peak IL-10
(r = 0.565, P < 0.001).
Conclusion: We found that plasma mtDNA might play a key role in CPB-induced post-operative inflammatory
responses.
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The first case of extracorporeal circulation (ECC) was
reported by Gibbon JH in 1954 to successfully save a pa-
tient with atrial septal defect (ASD) [1]. In 1955, Kirklin
et al. combined the ECC with the oxygenator in intra-
cardiac surgery and since then, the technique of cardio-
pulmonary bypass (CPB) was developed to be the key
process in modern cardiothoracic surgery [2]. While the* Correspondence: meng_wei_1111@yahoo.com
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lung during the operation, the abnormal status of circu-
lation and the ischemia/reperfusion injury (I/R injury)
may cause inflammatory responses [3]. It is well known
that most of postoperative complications are related to
the systemic inflammatory response syndrome (SIRS) and
many studies demonstrated that inflammatory mediators,
like tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-
8 and IL-10, increased significantly after cardiac surgery
with CPB [4–7]. Although many anti-inflammatory agents
and coated circuits were investigated to reduce the inflam-
matory responses after CPB, we still need a more efficient
way to eliminate the inflammatory responses and thenle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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organs [8, 9].
Human mitochondrial DNA (mtDNA) consist of 16569
nucleotide bases and take responsible for encoding 13
polypeptides of the electron transport chain, 22 transfer
RNAs, and 2 ribosomal RNAs [10]. mtDNA was released
into circulation and trigger inflammatory responses when
cells were dealing with harmful insults [11]. With the
pro-inflammatory CpG motif, mtDNA acts as a damage-
associated molecular patterns (DAMPs) [12]. It is docu-
mented that mtDNA played a pro-inflammatory role in
several diseases. Plasma mtDNA was elevated remarkably
in trauma patients, comparing to volunteers [13]. Re-
cently, a study based on multiple cohorts showed that
mtDNA can improve risk prediction and there is a tight
relationship between elevated plasma mtDNA level and
28-day mortality [14].
Given the pro-inflammatory features of mtDNA and
series of inflammatory responses after CPB, we hypothe-
sized that mtDNA may act as a pro-inflammatory factor
after cardiac surgery with CPB and play a key role in
post-CPB inflammatory responses with other inflamma-
tory factors, such as TNF-α, IL-6, IL-8 and IL-10.
Methods
Patients
Thirty-eight patients were included from January 2014
to August 2014, who were admitted to the Department
of Cardiovascular Surgery, West China Hospital, requir-
ing coronary artery bypass graft (CABG). Medical histor-
ies of endocarditis, diabetes, hypertension, neurological
diseases, psychiatric diseases, infectious diseases, and
post-surgical acute renal failure and low cardiac output
syndrome were designed as the excluding criteria. All pa-
tients had normal function of kidney, liver and lung prior
to surgery. Informed consents were signed by every pa-
tients. CABG with CPB and postoperative standard care
in cardiac intensive care unit (CICU) were performed
successfully for all patients. The study was conducted fol-
lowing the Declaration of Helsinki and registered in the
research committee at the Sichuan University.
Blood samples collection
Blood samples were collected in EDTA-coated blood
collection tube before aortic cross-clamping (T1), at the
end of CPB (T2), 6 h post-CPB (T3), 12 h post-CPB (T4),
24 h post-CPB (T5). The whole blood was centrifuged at
1000 rpm/min for 15 min at 4° and subsequently super-
natant was collected as plasma. Samples of plasma were
stored in -80° freezer and ready for rt-PCR and ELISA.
DNA isolation and rt-PCR for mtDNA
The whole plasma DNA was isolated from plasma using
the DNeasy Blood and Tissue Kit (#69504, Qiagen).Briefly, 50 μL plasma samples were added to50 μL phos-
phate buffered saline (PBS) and then centrifuged at
16000 g for 15 min at 4°. 90 μL of supernatant were kept
for the next procedures. The rest procedures were per-
formed according to the manufacture’s protocol. At the
last step, 200 μL elution buffer were added to resolve
the plasma DNA.
Plasma mtDNA levels were measured by SYBR-green
dye-based rt-PCR assay using a PRISM 7300 sequence
detection system. The primer sequences were human
NADH dehydrogenase 1 gene (mtDNA): forward CGA
GCAGTAGCCCAAACAAT, reverse TGTGATAAGGG
TGGAGAGGTT. Plasmid DNA with complementary
DNA sequence for human mtDNA was obtained from
ORIGENE (SC101172, USA). Concentration of plasma
mtDNA were converted to copy number via a DNA copy
number calculator (http://cels.uri.edu/gsc/cndna.html; Uni-
versity of Rhode Island Genomics and Sequencing Center).
Plasmid DNA were diluted in 10-fold serial dilutions and
measured as standard curve [14].
All samples were measured with standards at the same
time. Plasma mtDNA levels were shown in copies per
microliter of plasma according to the following formula:
c ¼ Q  VDNA= VPCR  1 = Vext
where c is the concentration of plasma mtDNA (copies/
μL); Q means the quantity of DNA measured by rt-PCR;
VDNA means the total volume of plasma DNA solution
obtained from the extraction, 200 μL in this study; VPCR
means the volume of plasma DNA solution for rt-PCR,
1 μL in this study; Vext means the volume of plasma
used for the extraction, 50 μL in this study.
Measurement of cytokines
Plasma TNF-α, IL-6, IL-8 and IL-10 were measured by
enzyme-linked immunosorbent assay (ELISA) kit (Solar-
bio, China). All procedures were followed standard pro-
tocols (included in the ELISA kits). Spectrophotometry
was used to detect the intensity of the transmitted light.
Data was expressed in picogram per mL.
Statistically analysis
All descriptive data were shown as mean ± standard error
of the mean (SEM). Multiple comparisons were analyzed
by one-way ANOVA followed by Bonferroni’s test. The
Pearson correlation coefficient test were performed. P <
0.05 was considered to statistically significant.
Results
Baseline information
Patient basic characteristics, surgery information and
laboratory data were presented in Table 1. 38 patients
were included and performed CABG successfully. During
Table 1 Baseline information
Characteristics N = 38
Age (years) 49.4 ± 12.7
Women 24 (63.2 %)
BMI (kg/m2) 23.2 ± 3.2
Emergency 7 (18.4 %)
Urgent 9 (23.7 %)
Elective 22 (57.9 %)
STEMI 5 (13.2 %)
NSTEMI 8 (21.1 %)
Stable angina 14 (36.8 %)
Unstable angina 11 (28.9 %)
Surgery information
Aortic Cross-clamping Time (min) 68 ± 21
CPB Time (min) 96 ± 27
Laboratory data
Serum Creatinine (μmol/L) 0.6 ± 0.2
Hemoglobin (g/L) 130.3 ± 11.7
Total Cholesterol (mg/dL) 198.2 ± 35.9
HDL (mmol/L) 1.1 ± 0.2
LDL (mmol/L) 2.9 ± 0.6
TG (mmol/L) 1.5 ± 0.4
Glucose (mg/dL) 140.1 ± 34.8
Hct (%) 39.4 ± 3.9
Variables are presented as mean ± SEM or as numbers (%). CPB cardiopulmonary
bypass, BMI Body mass index, STEMI ST elevated myocardial infarction, NSTEMI
Non- ST elevated myocardial infarction, HDL high density lipoprotein, LDL low
density lipoprotein, TG Triglycerides, Hct Hematocrit






















Fig. 1 Perioperative plasma mtDNA in CABG with CPB. Plasma
mtDNA levels after the end of CPB were significantly higher than T1.
The peak value of plasma mtDNA appeared at T4. Level of plasma
mtDNA at T5 was lower than T4, but still higher than T1. *P < 0.05
vs. T1. #P < 0.05 vs. T4
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(68 ± 21) min and the average CPB time is (96 ± 27) min.
On admission, we collected the baseline levels of serum
creatinine, hemoglobin, total cholesterol (TC), high dens-
ity lipoprotein (HDL), low density lipoprotein (LDL), tri-
glycerides (TG), glucose and hematocrit (Hct).
Changes of perioperative plasma mtDNA levels
Plasma mtDNA levels at different time points were
measured by rt-PCR. Given that much fluid was admin-
istered during the surgery, all plasma mtDNA results
were corrected based on the Hct measured on admis-
sion. As shown in Fig. 1, plasma mtDNA levels elevated
significantly after the end of CPB (T2) and peaked at
12 h post-CPB (T4), which decreased remarkably at 24 h
post-CPB (P < 0.05).
Changes of perioperative cytokines levels
TNF-α, IL-6, IL-8 and IL-10 were measured by specific
ELISA kits at the same time points. All concentrations
were corrected based on the Hct measured on admission.Merged curves of these four cytokines were presented in
Fig. 2. We found that all these cytokines but IL-6 began to
increase significantly after T2 (P < 0.05). However, the
highest concentrations of TNF-α and IL-8 appeared at T3,
while IL-10 climbed the peak value at T2 (P < 0.05).
Concentrations of IL-6 didn’t demonstrate a significant
different at T2 comparing with T1 (P > 0.05). Interestingly,
it peaked dramatically at T3 and then decreased gradually
(P < 0.05).
Correlations between plasma mtDNA and cytokines
Bivariate correlations analysis were used to study the
correlation between peak plasma mtDNA levels and
peak cytokines levels. Positively correlation between the
peak plasma mtDNA and the peak TNF-α (r = 0.697, P <
0.001), the peak IL-6 (r = 0.710, P < 0.001), the peak IL-8
(r = 0.527, P < 0.001) and the peak IL-10 (r = 0.535, P <
0.001) were confirmed and presented in Fig. 3.
Discussion
Our study demonstrated that plasma mtDNA was re-
leased during cardiac surgery with CPB. We found the
peak value of plasma mtDNA was shown up at 12 h post-
CPB through five time points tracking analysis. Mean-
while, we confirmed releasing patterns of inflammatory
cytokines, such as TNF-α, IL-6, IL-8 and IL-10, after car-
diac surgery with CPB. We revealed a significantly and
positively correlation between the peak plasma mtDNA
and peak cytokines levels.
CPB-induced systemic inflammatory response syn-
drome was affected by many factors, such as the contact
between blood and foreign surface of the extracorporeal
circuits, hypothermia, reduction of pulmonary blood


































Fig. 2 Merged curves of perioperative inflammatory cytokines in CABG with CPB. All inflammatory cytokines were elevated significantly after CPB
(P < 0.05). Levels of TNF-α, IL-6 and IL-8 peaked at T3 while levels of IL-10 peaked at T2 (P < 0.05)
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mia [15]. It is studied that excessive inflammatory re-
sponses might delay the recovery and attenuate hospital
outcomes [16]. As many studies reported, post-operative
inflammatory responses were almost happened in every
cardiac surgery with CPB, characterized with elevated
inflammatory cytokines [6, 17]. In addition, levels of
TNF-α, IL-6, IL-8 and IL-10, well-known inflammatory
cytokines, represented the severity of inflammatory re-
sponses. Dr. Mei YQ et al found that concentrations of
plasma IL-6 and IL-8 might be able to evaluate the se-
verity of SIRS after CABG and establish the prognosis
[18]. In the present study, we measured inflammatory
cytokine levels after CABG with CPB. We found that all
these inflammatory cytokines increased significantly
after surgery with CPB, which apparently demonstrated
that post-operative inflammatory responses occurred.
Except for IL-10, which peaking at the end of CPB, all
other cytokines peaked at 6 h post-CPB and levels of IL-
8 dropped dramatically after peak time while others
decreased gradually. Given that CPB-induced I/R condi-
tion may cause inflammatory responses [19], we suggest
that IL-10 may act as the factor indicating direct
damage-caused inflammatory responses while TNF-α,
IL-6, IL-8 may represent I/R injury-induced inflamma-
tory responses.It is well studied that mtDNA was released after
trauma surgery and the release of mtDNA happened in
a cell necrosis-independent way. Additionally, the study
also revealed that levels of plasma mtDNA were positively
correlation with the invasiveness and the complexation of
surgery [20]. As a pro-inflammatory agent, mtDNA was
studied in many different fields and was confirmed that it
can cause inflammatory responses [21–23]. Dr. Zhang Q
et al. revealed that circulating mtDNA, a kind of
mitochondrial damage-associated molecular patterns, can
cause inflammatory responses and create a sepsis-like
state [13]. In our study, after CABG with CPB, we found
that plasma mtDNA levels elevated after the end of CPB
and climbed to the peak value at 12 h post-CPB. And then
it decreased gradually but still higher than the baseline
level. It is reported that mtDNA was continuously released
for at least five days after surgery [20]. As mentioned
above, CPB, act as an I/R condition, can cause inflamma-
tory responses. Combing with our result, plasma mtDNA
elevation might indicate I/R injury-induced inflammatory
responses. After the end of CPB, post-ischemia reperfu-
sion caused secondary damage to the heart and late-
peaked plasma mtDNA may indicate this secondary I/R
injury-induced damage.
It is studied that plasma mtDNA can be a promising
predictor for ICU stay and 28-day mortality [14]. In our
Fig. 3 Correlation between the peak plasma mtDNA and peak inflammatory cytokines. a Scatter graph and the bivariate analysis demonstrated
positive correlation between the peak plasma mtDNA and the peak TNF-α (r = 0.697, P < 0.001, y = 0.41x – 103.57). b Scatter graph and the
bivariate analysis demonstrated positive correlation between the peak plasma mtDNA and the peak IL-6 (r = 0.710, P < 0.001, y = 0.52x – 108.68).
c Scatter graph and the bivariate analysis demonstrated positive correlation between the peak plasma mtDNA and the peak IL-8 (r = 0.527,
P < 0.001, y = 0.08x + 24.14). d Scatter graph and the bivariate analysis demonstrated positive correlation between the peak plasma mtDNA and
the peak IL-10 (r = 0.535, P < 0.001, y = 0.45x + 361.63)
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surprising positively correlation between the peak plasma
mtDNA and the peak inflammatory cytokines. It is well
known that excessive production of inflammatory cyto-
kines may be a predictor for outcomes in different dis-
eases and treatments [24, 25]. Considering that positively
correlation between plasma mtDNA and inflammatory cy-
tokines, we suggested that mtDNA might be involved in
the progression of post-operative inflammatory responses.Conclusions
Our study found that release of mtDNA after cardiac
surgery with CPB and positively correlation betweenplasma mtDNA and inflammatory cytokines, suggesting
that mtDNA may play an important role in inflammatory
responses after CPB. Our data strongly recommended a
new insightful point at attenuating post-operative inflam-
mation, which need further studies to illustrate more
details about mtDNA-relative mechanism and effects.
Additionally, considering that peak time of plasma
mtDNA was 12 h post-CPB, later than other inflamma-
tory cytokines, we need further studies to figure out the
interaction between mtDNA and other inflammatory
cytokines.
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